Cargando…

PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix

Peroxisome proliferator activated receptor γ (PPARγ) is a nuclear receptor and target for antidiabetics that increase insulin sensitivity. Owing to the side effects of PPARγ full agonists, research has recently focused on non-activating ligands of PPARγ, which increase insulin sensitivity with decre...

Descripción completa

Detalles Bibliográficos
Autores principales: Frkic, Rebecca L., Marshall, Andrew C., Blayo, Anne-Laure, Pukala, Tara L., Kamenecka, Theodore M., Griffin, Patrick R., Bruning, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095676/
https://www.ncbi.nlm.nih.gov/pubmed/30123887
http://dx.doi.org/10.1016/j.isci.2018.06.012
_version_ 1783347981785759744
author Frkic, Rebecca L.
Marshall, Andrew C.
Blayo, Anne-Laure
Pukala, Tara L.
Kamenecka, Theodore M.
Griffin, Patrick R.
Bruning, John B.
author_facet Frkic, Rebecca L.
Marshall, Andrew C.
Blayo, Anne-Laure
Pukala, Tara L.
Kamenecka, Theodore M.
Griffin, Patrick R.
Bruning, John B.
author_sort Frkic, Rebecca L.
collection PubMed
description Peroxisome proliferator activated receptor γ (PPARγ) is a nuclear receptor and target for antidiabetics that increase insulin sensitivity. Owing to the side effects of PPARγ full agonists, research has recently focused on non-activating ligands of PPARγ, which increase insulin sensitivity with decreased side effects. Here, we present the crystal structures of inverse agonist SR10171 and a chemically related antagonist SR11023 bound to the PPARγ ligand-binding domain, revealing an allosteric switch in the activation helix, helix 12 (H12), forming an antagonist conformation in the receptor. H12 interacts with the antagonists to become fixed in an alternative location. Native mass spectrometry indicates that this prevents contacts with coactivator peptides and allows binding of corepressor peptides. Antagonists of related nuclear receptors act to sterically prevent the active configuration of H12, whereas these antagonists of PPARγ alternatively trap H12 in an inactive configuration, which we have termed the tumble and trap mechanism.
format Online
Article
Text
id pubmed-6095676
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60956762018-08-16 PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix Frkic, Rebecca L. Marshall, Andrew C. Blayo, Anne-Laure Pukala, Tara L. Kamenecka, Theodore M. Griffin, Patrick R. Bruning, John B. iScience Article Peroxisome proliferator activated receptor γ (PPARγ) is a nuclear receptor and target for antidiabetics that increase insulin sensitivity. Owing to the side effects of PPARγ full agonists, research has recently focused on non-activating ligands of PPARγ, which increase insulin sensitivity with decreased side effects. Here, we present the crystal structures of inverse agonist SR10171 and a chemically related antagonist SR11023 bound to the PPARγ ligand-binding domain, revealing an allosteric switch in the activation helix, helix 12 (H12), forming an antagonist conformation in the receptor. H12 interacts with the antagonists to become fixed in an alternative location. Native mass spectrometry indicates that this prevents contacts with coactivator peptides and allows binding of corepressor peptides. Antagonists of related nuclear receptors act to sterically prevent the active configuration of H12, whereas these antagonists of PPARγ alternatively trap H12 in an inactive configuration, which we have termed the tumble and trap mechanism. Elsevier 2018-06-30 /pmc/articles/PMC6095676/ /pubmed/30123887 http://dx.doi.org/10.1016/j.isci.2018.06.012 Text en © 2018 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Frkic, Rebecca L.
Marshall, Andrew C.
Blayo, Anne-Laure
Pukala, Tara L.
Kamenecka, Theodore M.
Griffin, Patrick R.
Bruning, John B.
PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix
title PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix
title_full PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix
title_fullStr PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix
title_full_unstemmed PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix
title_short PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix
title_sort pparγ in complex with an antagonist and inverse agonist: a tumble and trap mechanism of the activation helix
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095676/
https://www.ncbi.nlm.nih.gov/pubmed/30123887
http://dx.doi.org/10.1016/j.isci.2018.06.012
work_keys_str_mv AT frkicrebeccal ppargincomplexwithanantagonistandinverseagonistatumbleandtrapmechanismoftheactivationhelix
AT marshallandrewc ppargincomplexwithanantagonistandinverseagonistatumbleandtrapmechanismoftheactivationhelix
AT blayoannelaure ppargincomplexwithanantagonistandinverseagonistatumbleandtrapmechanismoftheactivationhelix
AT pukalataral ppargincomplexwithanantagonistandinverseagonistatumbleandtrapmechanismoftheactivationhelix
AT kameneckatheodorem ppargincomplexwithanantagonistandinverseagonistatumbleandtrapmechanismoftheactivationhelix
AT griffinpatrickr ppargincomplexwithanantagonistandinverseagonistatumbleandtrapmechanismoftheactivationhelix
AT bruningjohnb ppargincomplexwithanantagonistandinverseagonistatumbleandtrapmechanismoftheactivationhelix